NEIMETH logo

Neimeth International Pharmaceuticals Plc Stock Price

NGSE:NEIMETH Community·₦47.0b Market Cap
  • 1 Narratives written by author
  • 10 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

NEIMETH Share Price Performance

₦10.70
7.70 (256.67%)
₦10.70
7.70 (256.67%)
Price ₦10.70

NEIMETH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
1 Reward

Neimeth International Pharmaceuticals Plc Key Details

₦7.4b

Revenue

₦4.1b

Cost of Revenue

₦3.3b

Gross Profit

₦2.3b

Other Expenses

₦982.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.23
44.96%
13.33%
367.6%
View Full Analysis

About NEIMETH

Founded
1957
Employees
175
CEO
J. Valentine Okelu
WebsiteView website
www.neimethplc.com.ng

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria.

Recent NEIMETH News & Updates

Recent updates

No updates

Neimeth International Pharmaceuticals Plc Competitors